Age (years) | Sex | Time after HTX (months) | Recent verified infection or events predisposing to infection | Antimicrobial therapy | Surgical treatment | Follow-up (months) | Clinical outcome | Reference |
---|---|---|---|---|---|---|---|---|
39 | Male | 5 | Pseudomonas aeruginosa septicaemia and positive urine culture | iv. Tobramycin, ceftazidime (6 weeks) | Resection, end-to-end anastomosis | 8 | unrelated death | Palac RT, et al. 1991 |
26 | Male | 15 | Cystic fibrosis, heart–lung transplantation, Pseudomonas aeruginosa bronchitis | iv. Unspecified antibiotics (61 days) po. ciprofloxacin (continuously) | Direct repair (autologous pericardium) | 5 | operation due to recurrence, (resection of pseudoaneurysm and heterologous graft implantation), then unrelated death after 7 months | Cassart M, et al. 1994 |
31 | Male | 2 | N/A | N/A | Resection, allograft implantation | N/A | reoperation due to recurrence, then recovered | McGiffin DC, et al. 1994 |
60 | Male | N/A | Diabetes mellitus, mediastinitis | iv. Unspecified antibiotics (6 weeks) | Repair with allograft patch | 34 | recovered | Knosalla C, et al. 1996 |
N/A | N/A | 8 | Pseudomonas pneumonia | Unspecified antibiotics (4–6 weeks) | Collagen-sealed vascular graft implantation | 2 | reoperation due to recurrence, then death due to bleeding through bronchial fistula | Koyanagi T, et al. 1999 |
57 | Male | 29 | Infected retained LVAD driveline (Pseudomonas aeruginosa) | iv. Unspecified antibiotics (≥ 6 weeks) | Resection, prosthetic graft implantation, pectoralis flap | 1 | recovered | Tang GHL, et al. 2011 |
44 | Male | 1.4 | RVAD outflow graft infection, septicaemia (Pseudomonas aeruginosa) | Unspecified antibiotics | After 3 weeks: resection, allograft implantation | N/A | N/A | Mirzaee S, et al. 2016 |
45 | Male | 1.1 | Pseudomonas isolated from previous LVAD exit site | iv. Ceftolozane/tazobactam (8 weeks) po. ciprofloxacin (lifelong) | Resection, allograft implantation | 8,3 | recovered | Aye C, et al. 2017 |